Psoriasis is a chronic autoimmune disorder that primarily affects the skin, causing it to become thick, red, and scaly. Several conditions, such as psoriatic arthritis, chronic obstructive pulmonary disease (COPD), and polycystic ovarian syndrome (PCOS), are linked to psoriasis. Patients with psoriasis are highly likely to develop certain health conditions due to inflammation and insulin response associated with psoriasis:
1. Psoriatic arthritis (PsA)
It is a type of inflammatory arthritis that affects people with psoriasis. PsA causes joint pain, stiffness, and swelling and can damage joints if left untreated. Up to 30% of people with psoriasis develop PsA. The link between psoriasis and PsA is thought to be related to the immune system. The immune system attacks healthy cells in both conditions, causing inflammation and damage. Researchers believe psoriasis triggers an immune response that can also attack the joints, leading to PsA.
2. Chronic obstructive pulmonary disease COPD
COPD is a lung disease that causes breathing difficulties, coughing, and wheezing. Patients with psoriasis are more likely to develop COPD than those without the condition. The link between psoriasis and COPD is not yet fully comprehended, but it is thought to be related to inflammation. Inflammation is a hallmark of both psoriasis and COPD, and it is believed that the chronic inflammation linked with psoriasis may lead to the development of COPD.
3. Lymphoma
It is cancer that attacks the lymphatic system, part of the immune system. People with psoriasis are at a slightly higher risk of developing it compared to the general population. The link between psoriasis and this condition is thought to be related to the immune system. The immune system is overactive in both conditions, which may increase the risk of developing lymphoma.
4. Polycystic ovarian Syndrome PCOS
It is a hormonal disorder that attacks women. It causes various symptoms, including irregular periods, weight gain, acne, and excess hair growth. Women with psoriasis are more likely to develop PCOS than those without the condition. The link between psoriasis and PCOS is not yet fully comprehended, but it is thought to be related to inflammation. Inflammation is a hallmark of both psoriasis and PCOS, and it is believed that the chronic inflammation linked with psoriasis may contribute to the development of PCOS.
5. Depression
It is a popular mental health condition that affects millions of people worldwide. Individuals with psoriasis are at an increased risk of developing this condition compared to the general population. The link between psoriasis and depression is thought to be related to the psychological impact of living with a chronic skin condition. Psoriasis can be unsightly, itchy, and painful, significantly impacting a person’s quality of life. Living with psoriasis can also lead to feelings of social isolation, stigma, and anxiety, all of which can contribute to melancholy.
6. Health Disease
It is a range of conditions that impacts the heart and blood vessels, including high blood pressure, heart failure, and coronary artery infection. People with psoriasis are at a high threat of developing this disease compared to those without the condition. The link between heart disease and psoriasis is thought to be related to inflammation. Chronic inflammation is a known risk factor for heart disease, and people with psoriasis have higher levels of inflammation in their bodies than those without the condition.
Usually, psoriasis can affect some body parts, including the joints, lungs, heart, and ovaries. Psoriasis may contribute to the development of heart disease by increasing the risk of metabolic syndrome, a cluster of conditions like high blood pressure and blood pressure. It also causes depression, lymphoma, pulmonary disease, psoriatic arthritis, polycystic ovarian syndrome, and chronic obstructive. The main objective of psoriasis treatment is to prevent the rapid growth of skin cells and to remove scales. Some common medical treatment for psoriasis includes Tremfya, Stelara, Rituximab, Skyrizi, Ilumya tildrakizumab, Cosentyx, Otezla, Xeljanx, and gene therapy.
